title: Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
authors.affiliation: Vascular Surgery, University of Missouri Health System, Columbia, Columbia, MO 65212, USA. gilpinv@health.missouri.edu
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Gilpin
mesh_terms: D000572:American Heart Association; D001241:Aspirin / Q000627:therapeutic use*; D002309:Cardiology / Q000639:trends; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D040242:Risk Reduction Behavior; D012955:Societies, Medical; D014481:United States; D003245:Consensus Statements as Topic
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin